✦ LIBER ✦

Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis

✍ Scribed by M. Etemadifar; M. Janghorbani; V. Shaygannejad

Publisher: Springer
Year: 2007
Tongue: English
Weight: 264 KB
Volume: 254
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-007-0637-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of beta-interferon treatment in

Outcome of beta-interferon treatment in relapsing-remitting multiple sclerosis: a Bayesian analysis

✍ K. O'Rourke; C. Walsh; M. Hutchinson 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

Interferon-β treatment and the natural h

Interferon-β treatment and the natural history of relapsing-remitting multiple sclerosis

✍ Marcus Koch; Jop Mostert; Jacques De Keyser; Helen Tremlett; Graziella Filippini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 1 views

Occurrence of thyroid autoimmunity in re

Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-β treatment

✍ V. Martinelli; M. Gironi; M. Rodegher; G. Martino; G. Comi 📂 Article 📅 1998 🏛 Springer Milan 🌐 English ⚖ 265 KB

Predictive factors of neutralizing antib

Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy

✍ R. Lanzillo; G. Orefice; A. Prinster; G. Ventrella; R. Liuzzi; V. Scarano; C. Fl 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 174 KB

The combination of cyclophosphamide plus

The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing–remitting multiple sclerosis patients

✍ E. Reggio; A. Nicoletti; T. Fiorilla; G. Politi; A. Reggio; F. Patti 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 256 KB

Intravenous natural beta interferon trea

Intravenous natural beta interferon treatment of chronic exacerbating-remitting multiple sclerosis: clinical response and MRI/CSF findings

✍ M. Huber; S. Bamborschke; J. Assheuer; W. -D. Heiß 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 235 KB

A preliminary study is reported of clinical response and CSF/MRI findings in nine patients with multiple sclerosis receiving intravenous infusions of natural beta-interferon. The mean patient follow-up was for 1.2 years. Neither exacerbation rates nor CSF-IgG synthesis nor plaque formation as reveal